KalVista Pharmaceuticals Inc logo

KalVista Pharmaceuticals Inc

NEW
NAS:KALV (USA)  
$ 10.28 -0.93 (-8.3%) 07:08 PM EST
At Loss
P/B:
2.56
Market Cap:
$ 443.82M
Enterprise V:
$ 315.99M
Volume:
451.58K
Avg Vol (2M):
379.33K
Trade In:
Volume:
451.58K
At Loss
Avg Vol (2M):
379.33K

Business Description

Description
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
Name Current Vs Industry Vs History
Cash-To-Debt 27.88
Equity-to-Asset 0.86
Debt-to-Equity 0.04
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.55
Quick Ratio 8.55
Cash Ratio 7.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3
Shareholder Yield % 0.24

Financials (Next Earnings Date:2024-12-06 Est.)

KALV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KALV

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

KalVista Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.58
Beta -0.18
Volatility % 66.62
14-Day RSI 43.92
14-Day ATR ($) 0.554596
20-Day SMA ($) 11.769
12-1 Month Momentum % 36.4
52-Week Range ($) 7.21 - 16.88
Shares Outstanding (Mil) 43.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

KalVista Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

KalVista Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

KalVista Pharmaceuticals Inc Frequently Asked Questions

What is KalVista Pharmaceuticals Inc(KALV)'s stock price today?
The current price of KALV is $10.28. The 52 week high of KALV is $16.88 and 52 week low is $7.21.
When is next earnings date of KalVista Pharmaceuticals Inc(KALV)?
The next earnings date of KalVista Pharmaceuticals Inc(KALV) is 2024-12-06 Est..
Does KalVista Pharmaceuticals Inc(KALV) pay dividends? If so, how much?
KalVista Pharmaceuticals Inc(KALV) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1